These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1029 related articles for article (PubMed ID: 6432420)

  • 1. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third generation cephalosporins.
    Donowitz GR
    Infect Dis Clin North Am; 1989 Sep; 3(3):595-612. PubMed ID: 2671141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H; Kulpradist S; Manalaysay M; Soebandrio A
    J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of third-generation cephalosporins in the treatment of bacterial meningitis.
    Modai J
    Chemioterapia; 1986 Oct; 5(5):313-8. PubMed ID: 3791477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cephalosporins with enhanced anti-anaerobic activity for treatment and prevention of anaerobic and mixed infections.
    DiPiro JT; May JR
    Clin Pharm; 1988 Apr; 7(4):285-302. PubMed ID: 3284692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activities of third-generation cephalosporins.
    Fass RJ
    Arch Intern Med; 1983 Sep; 143(9):1743-5. PubMed ID: 6615095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selection and use of cephalosporins: a review.
    Klein NC; Cunha BA
    Adv Ther; 1995; 12(2):83-101. PubMed ID: 10150326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory evaluation of cefoperazone.
    Sarver DK; Christensen GD; Hester MG; Ling FW; Pate JW; Rosenberg EW; Anderson GD; Bisno AL
    Clin Ther; 1981; 4(3):164-74. PubMed ID: 6458360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefuroxime: mechanisms of action, antimicrobial activity, pharmacokinetics, clinical applications, adverse reactions and therapeutic indications.
    Gold B; Rodriguez WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):82-100. PubMed ID: 6344037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-negative bacillary meningitis. New therapy and changing concepts.
    Landesman SH; Cherubin CE; Corrado ML
    Arch Intern Med; 1982 May; 142(5):939-40. PubMed ID: 6211153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotaxime: microbiology, pharmacology, and clinical use.
    Dudley MN; Barriere SL
    Clin Pharm; 1982; 1(2):114-24. PubMed ID: 6309465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of moxalactam.
    Reed MD; Bertino JS; Aronoff SC; Speck WT; Blumer JL
    Clin Pharm; 1982; 1(2):124-34. PubMed ID: 6224626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime: a new fourth-generation cephalosporin.
    Okamoto MP; Nakahiro RK; Chin A; Bedikian A; Gill MA
    Am J Hosp Pharm; 1994 Feb; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.